Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Glycorex Transplantation

1.34 SEK

-4.29 %

Less than 1K followers

GTAB B

NGM Main Regulated

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Glycorex Transplantation

P/E

Median 2019-2025

EV/S

Median 2019-2022

EV/EBIT

Median 2019-2022

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)10.4011.509.304.101.332.041.59
Shares69.973.373.973.973.973.978.9
Market cap726.5843.2686.8302.897.9150.7125.4
Enterprise value725.2803.3653.8270.6---
EV/S20.129.823.27.5---
EV/EBITDA57.67,578.0neg.1,082.2---
EV/EBIT96.7neg.neg.neg.---
P/E105.3neg.neg.neg.neg.neg.neg.
P/B11.478.868.284.072.224.553.63
P/S20.131.224.48.43.34.33.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio73.8 %84.5 %81.5 %77.4 %66.9 %65.8 %68.0 %
Gearing ratio22.6 %9.8 %10.9 %1.8 %26.1 %21.1 %20.2 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.